These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
328 related items for PubMed ID: 15599664
1. Increased levels of interleukin-10 in saliva of Sjögren's syndrome patients. Correlation with disease activity. Bertorello R, Cordone MP, Contini P, Rossi P, Indiveri F, Puppo F, Cordone G. Clin Exp Med; 2004 Dec; 4(3):148-51. PubMed ID: 15599664 [Abstract] [Full Text] [Related]
2. Salivary and serum interleukin 6 in primary Sjögren's syndrome. Grisius MM, Bermudez DK, Fox PC. J Rheumatol; 1997 Jun; 24(6):1089-91. PubMed ID: 9195514 [Abstract] [Full Text] [Related]
3. Increased serum levels of interleukin 10 in Sjögren's syndrome; correlation with increased IgG1. Perrier S, Serre AF, Dubost JJ, Beaujon G, Plazonnet MP, Albuisson E, Sauvezie B. J Rheumatol; 2000 Apr; 27(4):935-9. PubMed ID: 10782819 [Abstract] [Full Text] [Related]
4. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland. Jonsson MV, Delaleu N, Brokstad KA, Berggreen E, Skarstein K. Arthritis Rheum; 2006 Jul; 54(7):2300-5. PubMed ID: 16802370 [Abstract] [Full Text] [Related]
5. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome. van Woerkom JM, Kruize AA, Wenting-van Wijk MJ, Knol E, Bihari IC, Jacobs JW, Bijlsma JW, Lafeber FP, van Roon JA. Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659 [Abstract] [Full Text] [Related]
6. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans. Shen L, Suresh L, Li H, Zhang C, Kumar V, Pankewycz O, Ambrus JL. Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581 [Abstract] [Full Text] [Related]
7. The significance of salivary and serum interleukin 6 and basic fibroblast growth factor levels in patients with Sjögren's syndrome. Boras VV, Cikes N, Lukac J, Cekić-Arambasin A, Virag M, Bosnjak A. Coll Antropol; 2004 Mar; 28 Suppl 2():305-9. PubMed ID: 15571105 [Abstract] [Full Text] [Related]
8. [Salivary immunoglobulins in the diagnosis of primary Sjögren's syndrome]. Bianucci GF, Campana G, Maddali Bongi S, Palermo C, Castagnoli A. Minerva Med; 1993 Apr; 84(4):161-70. PubMed ID: 8506054 [Abstract] [Full Text] [Related]
9. Interleukin 10 (IL-10) influences autoimmune response in primary Sjögren's syndrome and is linked to IL-10 gene polymorphism. Anaya JM, Correa PA, Herrera M, Eskdale J, Gallagher G. J Rheumatol; 2002 Sep; 29(9):1874-6. PubMed ID: 12233881 [Abstract] [Full Text] [Related]
10. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development. Manoussakis MN, Boiu S, Korkolopoulou P, Kapsogeorgou EK, Kavantzas N, Ziakas P, Patsouris E, Moutsopoulos HM. Arthritis Rheum; 2007 Dec; 56(12):3977-88. PubMed ID: 18050195 [Abstract] [Full Text] [Related]
11. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome. Khurshudian AV. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025 [Abstract] [Full Text] [Related]
13. Chemokine saliva levels in patients with primary Sjögren's syndrome, associated Sjögren's syndrome, pre-clinical Sjögren's syndrome and systemic autoimmune diseases. Hernández-Molina G, Michel-Peregrina M, Hernández-Ramírez DF, Sánchez-Guerrero J, Llorente L. Rheumatology (Oxford); 2011 Jul; 50(7):1288-92. PubMed ID: 21330342 [Abstract] [Full Text] [Related]
14. Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients. Vitali C, Palombi G, Baldini C, Benucci M, Bombardieri S, Covelli M, Del Papa N, De Vita S, Epis O, Franceschini F, Gerli R, Govoni M, Bongi SM, Maglione W, Migliaresi S, Montecucco C, Orefice M, Priori R, Tavoni A, Valesini G. Arthritis Rheum; 2007 Jul; 56(7):2223-31. PubMed ID: 17599741 [Abstract] [Full Text] [Related]
15. Clinical and immunological characteristics of elderly onset Sjögren's syndrome: a comparison with younger onset disease. Tishler M, Yaron I, Shirazi I, Yaron M. J Rheumatol; 2001 Apr; 28(4):795-7. PubMed ID: 11327252 [Abstract] [Full Text] [Related]
16. Salivary anti-spectrin autoantibodies in Sjögren's syndrome. Moody M, Zipp M, Al-Hashimi I. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):322-7. PubMed ID: 11250630 [Abstract] [Full Text] [Related]
17. Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome. Kolkowski EC, Reth P, Pelusa F, Bosch J, Pujol-Borrell R, Coll J, Jaraquemada D. J Autoimmun; 1999 Aug; 13(1):155-62. PubMed ID: 10441181 [Abstract] [Full Text] [Related]
18. Minor salivary gland immunohistology in the diagnosis of primary Sjögren's syndrome. Salomonsson S, Rozell BL, Heimburger M, Wahren-Herlenius M. J Oral Pathol Med; 2009 Mar; 38(3):282-8. PubMed ID: 18793250 [Abstract] [Full Text] [Related]
19. Characterization of T-cell large granular lymphocyte leukemia associated with Sjogren's syndrome-an important but under-recognized association. Friedman J, Schattner A, Shvidel L, Berrebi A. Semin Arthritis Rheum; 2006 Apr; 35(5):306-11. PubMed ID: 16616153 [Abstract] [Full Text] [Related]
20. Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome. Hammi AR, Al-Hashimi IH, Nunn ME, Zipp M. J Oral Pathol Med; 2005 Apr; 34(4):198-203. PubMed ID: 15752253 [Abstract] [Full Text] [Related] Page: [Next] [New Search]